Active Ingredient: LAMIVUDINE; ZIDOVUDINE
Proprietary Name: LAMIVUDINE AND ZIDOVUDINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG;300MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A206375
Product Number: 001
Approval Date: Apr 10, 2018
Applicant Holder Full Name: ANDA REPOSITORY LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
